MicroRNAs in Cerebral Ischemia
- PMID: 23533957
- PMCID: PMC3606790
- DOI: 10.1155/2013/276540
MicroRNAs in Cerebral Ischemia
Abstract
The risk of ischemic stroke increases substantially with age, making it the third leading cause of death and the leading cause of long-term disability in the world. Numerous studies demonstrated that genes, RNAs, and proteins are involved in the occurrence and development of stroke. Current studies found that microRNAs (miRNAs or miRs) are also closely related to the pathological process of stroke. miRNAs are a group of short, noncoding RNA molecules playing important role in posttranscriptional regulation of gene expression and they have emerged as regulators of ischemic preconditioning and ischemic postconditioning. Here we give an overview of the expression and function of miRNAs in the brain, miRNAs as biomarkers during cerebral ischemia, and clinical applications and limitations of miRNAs. Future prospects of miRNAs are also discussed.
Figures
References
-
- Zhang C. Micrornomics: a newly emerging approach for disease biology. Physiological Genomics. 2008;33(2):139–147. - PubMed
-
- Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 2008;39(3):959–966. - PubMed
-
- Kloosterman WP, Plasterk RHA. The diverse functions of MicroRNAs in animal development and disease. Developmental Cell. 2006;11(4):441–450. - PubMed
-
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nature Reviews Cancer. 2006;6(11):857–866. - PubMed
-
- Hernando E. microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clinical and Translational Oncology. 2007;9(3):155–160. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
